Enoxacin therapy for severe pleuro-pulmonary infections.
Artigo
em Inglês
| IMSEAR
| ID: sea-92529
ABSTRACT
Enoxacin, a new 6-fluoroquinolone known to be active in vitro against most common pulmonary pathogens, was evaluated in comparison with ceftazidime, a third generation cephalosporin proven to be effective in the treatment of gram negative pneumonias. Clinical and microbiologic responses to therapy were satisfactory and comparable in both antibiotic groups. Enoxacin could be an effective alternative choice in the treatment of lower respiratory tract infections caused by gram negative organisms.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Pneumonia
/
Escarro
/
Feminino
/
Humanos
/
Masculino
/
Enoxacino
/
Ceftazidima
/
Estudos Prospectivos
/
Infecções por Bactérias Gram-Negativas
/
Adulto
Tipo de estudo:
Ensaio Clínico Controlado
/
Estudo observacional
Idioma:
Inglês
Ano de publicação:
1991
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS